This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


February 25–26, 2020
Hilton Alexandria Old Town,
Alexandria, VA

In-Depth Analysis on the Latest Policy and Reform Initiatives Impacting Pricing, Quality and Transparency

A meeting that goes beyond theory and policy to equip stakeholders with practical approaches during a time of uncertainty and the potential for seismic change.

What to Expect

In-Depth Discussions on High-Impact Issues
  • Policy trends and reform initiatives
  • International Pricing Index Model (IPI) and the Most Favored-Nations Clause
  • Part D drug spending and PBM utilization management
  • Reimbursement and value-based payment initiatives
Pricing and Contracting for Manufacturers
  • Biosimilar policy evolution and access strategy
  • Developments and updates in step therapy
  • Impact of international price benchmarks
  • Value-based contracting and outcomes arrangements as a driver for quality and innovation
Part D Strategies for Health Plans and PBMs
  • Preparing for the 2021 Medicare Advantage and Part D landscape
  • Opportunities and challenges of the current regulatory landscape
  • Trends in Medicare Advantage and Part D
  • Innovative approaches to social determinants of health (SDOH)